Robert Rosenthal

Performance

Overall performance
2.8

Performance over holding periods
2.8
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 5% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director MZT Holdings Inc Jan. 22, 2007 -
Director InVivo Therapeutics Holdings Corp Nov. 12, 2019 -
Executive Chairman of the Board, Principal Executive Officer Safeguard Scientifics Inc April 1, 2020 -
Independent Director Bruker Corp Nov. 11, 2015 -
Independent Chairman of the Board Safeguard Scientifics Inc May 19, 2016 - April 1, 2020
Independent Director Safeguard Scientifics Inc July 26, 2007 - May 19, 2016

Robert Rosenthal's trades of Bruker Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-16 2024-08-15 S Sale
4,152 +12.9%
302.70
US$3,363,573
4,152 +12.9% 302.70 US$3,363,573
2024-08-15 2024-08-15 PrS Proposed sale
95,847
378.70
US$4,136,604
95,847 378.70 US$4,136,604
2020-05-12 2020-05-11 B Purchase
9,766 -33.5%
209.62
US$502,164
9,766 -33.5% 209.62 US$502,164